The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
This session is a comprehensive approach to understanding Lean Management System concepts, processes, tools, and their application to improving…
On-Demand Educational Webinars
Health care costs continue to rise at an alarming rate, growing well ahead of inflation. In this webinar, we compare and contrast the education and…
On-Demand Educational Webinars
This webinar explains how supplier diversity can be a valuable investment toward sustainability. Presenters define supplier diversity and the…
On-Demand Educational Webinars
In order to compare baseline costs to savings and determine areas of compliance risk, supply chain professionals need to work closely with their…
Podcasts
Now that the entire healthcare field is increasing its focus on value-based care, supply chain and physicians are working more closely together.
On-Demand Educational Webinars
Cybersecurity impacts all industry verticals including health care. Health care organizations need to address security in standard technology and…